Setting

Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity

Published: 28 Feb 2023 | Report Code: 10248972 | Pages: 111

Europe genital herpes treatment market was valued at $958.5 million in 2022 and will grow by 4.1% annually over 2022-2032, driven by the rising prevalence of sexually transmitted diseases, changing socio-cultural openness, increasing awareness about HSV infection and its symptoms, improved access to antiviral medications, and the government supports. Highlighted with 35 tables and 45 figures, this 111-page report “Europe Genital Herpes Treatment Market 2022-2032 by Virus Type (HSV-1, HSV-2), Drug Type (Acyclovir, Valacyclovir, Famciclovir, Others), Route of Administration (Oral, Topical, Injection), Patient Gender (Female, Male), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe genital herpes treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe genital herpes treatment market in every aspect of the classification from perspectives Virus, Drug Type, Route of Administration, Patient Gender, Distribution Channel, and Country. Based on Virus Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • HSV-1 • HSV-2 Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Acyclovir • Valacyclovir • Famciclovir • Other Drugs By Route of Administration, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Oral • Topical • Injection By Patient Gender, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Female • Male By Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section. • Retail Pharmacies • Hospital Pharmacies • Online Pharmacies • Drug Stores Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Virus Type, Drug Type and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott ADLEY FORMULATIONS Aurobindo Pharma Ltd. Avet Pharmaceuticals Inc. Bausch Health Companies Centurion Remedies Cipla Ltd. Eli Lilly & Company Finecure Pharmaceuticals GlaxoSmithKline Plc Glenmark Pharmaceuticals Macleods Pharmaceuticals Medico Remedies Merck & Co., Inc. Novartis AG Pfizer Reddy's Laboratories Sanofi SA Teva Pharmaceutical Industries Ltd. Torrent Pharma Viatris Inc. Zeelab Pharmacy Zydus Pharmaceuticals, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	29
2.4 Emerging Opportunities and Market Trends	32
2.5 Porter’s Fiver Forces Analysis	36
3 Segmentation of Europe Market by Virus Type	40
3.1 Market Overview by Virus Type	40
3.2 HSV-1	42
3.3 HSV-2	43
4 Segmentation of Europe Market by Drug Type	44
4.1 Market Overview by Drug Type	44
4.2 Acyclovir	46
4.3 Valacyclovir	47
4.4 Famciclovir	48
4.5 Other Drugs	49
5 Segmentation of Europe Market by Route of Administration	51
5.1 Market Overview by Route of Administration	51
5.2 Oral	53
5.3 Topical	54
5.4 Injection	55
6 Segmentation of Europe Market by Patient Gender	56
6.1 Market Overview by Patient Gender	56
6.2 Female	58
6.3 Male	59
7 Segmentation of Europe Market by Distribution Channel	60
7.1 Market Overview by Distribution Channel	60
7.2 Retail Pharmacies	62
7.3 Hospital Pharmacies	63
7.4 Online Pharmacies	64
7.5 Drug Stores	65
8 European Market 2022-2032 by Country	66
8.1 Overview of European Market	66
8.2 Germany	69
8.3 U.K.	71
8.4 France	73
8.5 Spain	75
8.6 Italy	77
8.7 Netherlands	79
8.8 Rest of European Market	81
9 Competitive Landscape	83
9.1 Overview of Key Vendors	83
9.2 New Product Launch, Partnership, Investment, and M&A	86
9.3 Company Profiles	87
Abbott	87
ADLEY FORMULATIONS	89
Aurobindo Pharma Ltd.	90
Avet Pharmaceuticals Inc.	91
Bausch Health Companies	92
Centurion Remedies	93
Cipla Ltd.	94
Eli Lilly & Company	95
Finecure Pharmaceuticals	96
GlaxoSmithKline Plc	97
Glenmark Pharmaceuticals	98
Macleods Pharmaceuticals	99
Medico Remedies	100
Merck & Co., Inc.	101
Novartis AG	102
Pfizer	103
Reddy's Laboratories	104
Sanofi SA	105
Teva Pharmaceutical Industries Ltd.	106
Torrent Pharma	107
Viatris Inc.	108
Zeelab Pharmacy	109
Zydus Pharmaceuticals, Inc.	110
RELATED REPORTS	111
?
List of Tables:

Table 1.  Snapshot of Europe Genital Herpes Treatment Market in Balanced Perspective, 2022-2032	17
Table 2. World Economic Outlook, 2021-2031	21
Table 3. World Economic Outlook, 2021-2023	22
Table 4. World Health Spending by Region, $ bn, 2013-2020	28
Table 5.  Main Product Trends and Market Opportunities in Europe Genital Herpes Treatment Market	32
Table 6. Europe Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	40
Table 7. Europe Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	44
Table 8. Side Effects of Genital Herpes Medications	44
Table 9. Vaccine Pipelines for Herpes	50
Table 10. Europe Genital Herpes Treatment Market by Route of Administration, 2022-2032, $ mn	51
Table 11. Europe Genital Herpes Treatment Market by Patient Gender, 2022-2032, $ mn	56
Table 12. Europe Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	60
Table 13. Europe Genital Herpes Treatment Market by Country, 2022-2032, $ mn	68
Table 14. Germany Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	70
Table 15. Germany Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	70
Table 16. Germany Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	70
Table 17. U.K. Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	72
Table 18. U.K. Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	72
Table 19. U.K. Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	72
Table 20. France Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	74
Table 21. France Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	74
Table 22. France Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	74
Table 23. Spain Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	76
Table 24. Spain Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	76
Table 25. Spain Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	76
Table 26. Italy Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	78
Table 27. Italy Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	78
Table 28. Italy Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	78
Table 29. Netherlands Genital Herpes Treatment Market by Virus Type, 2022-2032, $ mn	80
Table 30. Netherlands Genital Herpes Treatment Market by Drug Type, 2022-2032, $ mn	80
Table 31. Netherlands Genital Herpes Treatment Market by Distribution Channel, 2022-2032, $ mn	80
Table 32. Genital Herpes Treatment Market in Rest of Europe by Country, 2022-2032, $ mn	82
Table 33. Abbott: Company Snapshot	87
Table 34. Abbott: Business Segmentation	88
Table 35. Abbott: Product Portfolio	88

List of Figures:

Figure 1. Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032	16
Figure 4. Europe Genital Herpes Treatment Market, 2022-2032, $ mn	19
Figure 5. Impact of COVID-19 on Business	23
Figure 6. Primary Drivers and Impact Factors of Europe Genital Herpes Treatment Market	25
Figure 7. Forecast of Middle-class Population by Region, 2015-2030, million	28
Figure 8. Primary Restraints and Impact Factors of Europe Genital Herpes Treatment Market	29
Figure 9. Investment Opportunity Analysis	33
Figure 10. Porter’s Fiver Forces Analysis of Europe Genital Herpes Treatment Market	36
Figure 11. Breakdown of Europe Genital Herpes Treatment Market by Virus Type, 2022-2032, % of Revenue	41
Figure 12. Europe Addressable Market Cap in 2023-2032 by Virus Type, Value ($ mn) and Share (%)	41
Figure 13. Europe Genital Herpes Treatment Market by Virus Type: HSV-1, 2022-2032, $ mn	42
Figure 14. Europe Genital Herpes Treatment Market by Virus Type: HSV-2, 2022-2032, $ mn	43
Figure 15. Breakdown of Europe Genital Herpes Treatment Market by Drug Type, 2022-2032, % of Sales Revenue	45
Figure 16. Europe Addressable Market Cap in 2023-2032 by Drug Type, Value ($ mn) and Share (%)	45
Figure 17. Europe Genital Herpes Treatment Market by Drug Type: Acyclovir, 2022-2032, $ mn	46
Figure 18. Europe Genital Herpes Treatment Market by Drug Type: Valacyclovir, 2022-2032, $ mn	47
Figure 19. Europe Genital Herpes Treatment Market by Drug Type: Famciclovir, 2022-2032, $ mn	48
Figure 20. Europe Genital Herpes Treatment Market by Drug Type: Other Drugs, 2022-2032, $ mn	49
Figure 21. Breakdown of Europe Genital Herpes Treatment Market by Route of Administration, 2022-2032, % of Sales Revenue	52
Figure 22. Europe Addressable Market Cap in 2023-2032 by Route of Administration, Value ($ mn) and Share (%)	52
Figure 23. Europe Genital Herpes Treatment Market by Route of Administration: Oral, 2022-2032, $ mn	53
Figure 24. Europe Genital Herpes Treatment Market by Route of Administration: Topical, 2022-2032, $ mn	54
Figure 25. Europe Genital Herpes Treatment Market by Route of Administration: Injection, 2022-2032, $ mn	55
Figure 26. Breakdown of Europe Genital Herpes Treatment Market by Patient Gender, 2022-2032, % of Revenue	57
Figure 27. Europe Addressable Market Cap in 2023-2032 by Patient Gender, Value ($ mn) and Share (%)	57
Figure 28. Europe Genital Herpes Treatment Market by Patient Gender: Female, 2022-2032, $ mn	58
Figure 29. Europe Genital Herpes Treatment Market by Patient Gender: Male, 2022-2032, $ mn	59
Figure 30. Breakdown of Europe Genital Herpes Treatment Market by Distribution Channel, 2022-2032, % of Revenue	61
Figure 31. Europe Addressable Market Cap in 2023-2032 by Distribution Channel, Value ($ mn) and Share (%)	61
Figure 32. Europe Genital Herpes Treatment Market by Distribution Channel: Retail Pharmacies, 2022-2032, $ mn	62
Figure 33. Europe Genital Herpes Treatment Market by Distribution Channel: Hospital Pharmacies, 2022-2032, $ mn	63
Figure 34. Europe Genital Herpes Treatment Market by Distribution Channel: Online Pharmacies, 2022-2032, $ mn	64
Figure 35. Europe Genital Herpes Treatment Market by Distribution Channel: Drug Stores, 2022-2032, $ mn	65
Figure 36. Breakdown of European Genital Herpes Treatment Market by Country, 2022 and 2032, % of Revenue	67
Figure 37. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)	68
Figure 38.  Genital Herpes Treatment Market in Germany, 2022-2032, $ mn	69
Figure 39.  Genital Herpes Treatment Market in U.K., 2022-2032, $ mn	71
Figure 40.  Genital Herpes Treatment Market in France, 2022-2032, $ mn	73
Figure 41.  Genital Herpes Treatment Market in Spain, 2022-2032, $ mn	75
Figure 42.  Genital Herpes Treatment Market in Italy, 2022-2032, $ mn	77
Figure 43.  Genital Herpes Treatment Market in Netherlands, 2022-2032, $ mn	79
Figure 44.  Genital Herpes Treatment Market in Rest of Europe, 2022-2032, $ mn	81
Figure 45. Growth Stage of Europe Genital Herpes Treatment Industry over the Forecast Period	83

Selected Key Players: 
Abbott
ADLEY FORMULATIONS
Aurobindo Pharma Ltd.
Avet Pharmaceuticals Inc.
Bausch Health Companies
Centurion Remedies
Cipla Ltd.
Eli Lilly & Company
Finecure Pharmaceuticals
GlaxoSmithKline Plc
Glenmark Pharmaceuticals
Macleods Pharmaceuticals
Medico Remedies
Merck & Co., Inc.
Novartis AG
Pfizer
Reddy's Laboratories
Sanofi SA
Teva Pharmaceutical Industries Ltd.
Torrent Pharma
Viatris Inc.
Zeelab Pharmacy
Zydus Pharmaceuticals, Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)